Table 2

SFB loading in the clinical samples studied

Sample name/number	Age	Sex	Activity	CT SFB	CT IL-8	Fold SFB/IL-8
Healthy subjects
a	70	Male	n.a.	28.55	24.32	1
b	67	Male	n.a.	26.36	24.62	5.62
c	50	Female	n.a.	29.82	24.14	0.37
d	68	Female	n.a.	29.58	24.11	0.42
e	72	Male	n.a.	23.98	24.06	19.84
f	65	Female	n.a.	26.31	23.72	3.11
g	36	Female	n.a.	27.42	23.89	1.62
h	55	Male	n.a.	32.15	24.46	0.09
RCU subjects
1	52	Male	Remission	31.58	24.58	0.15
2	48	Male	Active	29.77	24.41	0.4
8	70	Male	Active	25.61	24.08	6.48
9	28	Female	Active	28.1	24.75	1.83
3	35	Male	Active	28.65	24.23	0.88
4	42	Female	Active	27.15	24.34	2.68
5	35	Female	Remission	31.17	24.54	0.19
6	66	Male	Remission	32.98	24.55	0.05
7	54	Male	Remission	27.61	24.99	3.04
10	40	Female	Remission	31.66	24.11	0.1

IL-8, interleukin-8; SFB, segmented filamentous bacteria.